Summary
SYENSQO is a financial institution; the bankruptcy model is trained on trading and manufacturing companies and does not apply here. The 2024 annual accounts show equity of €7.58B and a net result of €-215.40M. The company has been active since 2023 and the Belgian State Gazette contains no insolvency or warning signals.
Checked score
Credit check for your own amount and term
Signals
Checked, nothing found (2)
Financials · fiscal year 2024, full schema, statutory accounts
Filed annual accounts As filed with the NBB · 2024 against 2023 · 99 lines
The notes to these accounts (126 items: statements of assets and debts, cost breakdowns, rights and commitments) are not shown here.
| Line | 2023 | 2024 | Change |
|---|---|---|---|
| Operating income70/76A | €239.21M | €779.96M | ▲ 226% |
| Own construction capitalised72 | €9.48M | €22.37M | ▲ 136% |
| Other operating income74 | €179.74M | €681.11M | ▲ 279% |
| Non-recurring operating income76A | €49.99M | €76.49M | ▲ 53.0% |
| Operating charges60/66A | €389.20M | €771.15M | ▲ 98.1% |
| Goods for resale, raw materials and consumables60 | €322k | €818k | ▲ 154% |
| Purchases600/8 | €322k | €818k | ▲ 154% |
| Services and other goods61 | €190.36M | €483.19M | ▲ 154% |
| Remuneration, social security and pensions62 | €40.51M | €95.76M | ▲ 136% |
| Depreciation of and write-downs on formation expenses, intangible and tangible fixed assets630 | €11.02M | €24.88M | ▲ 126% |
| Write-downs on stocks, contracts in progress and trade receivables: additions (reversals)631/4 | €12.80M | €16.83M | ▲ 31.5% |
| Provisions for liabilities and charges: additions (uses and reversals)635/8 | €-29.09M | €23.33M | ▲ 180% |
| Other operating charges640/8 | €12.69M | €11.80M | ▼ 7.0% |
| Non-recurring operating charges66A | €150.59M | €114.54M | ▼ 23.9% |
| Operating profit (loss)9901 | €-149.99M | €8.81M | ▲ 106% |
| Financial income75/76B | €153.25M | €327.25M | ▲ 114% |
| Recurring financial income75 | €151.95M | €327.21M | ▲ 115% |
| Income from financial fixed assets750 | €80k | €142.23M | ▲ 176,981% |
| Income from current assets751 | €65.11M | €104.76M | ▲ 60.9% |
| Other financial income752/9 | €86.76M | €80.22M | ▼ 7.5% |
| Non-recurring financial income76B | €1.30M | €40k | ▼ 96.9% |
| Financial charges65/66B | €301.73M | €540.40M | ▲ 79.1% |
| Recurring financial charges65 | €162.95M | €191.91M | ▲ 17.8% |
| Debt charges650 | €87.09M | €111.31M | ▲ 27.8% |
| Other financial charges652/9 | €75.86M | €80.61M | ▲ 6.3% |
| Non-recurring financial charges66B | €138.78M | €348.49M | ▲ 151% |
| Profit (loss) for the period before taxes9903 | €-298.47M | €-204.34M | ▲ 31.5% |
| Income taxes67/77 | €1.16M | €11.06M | ▲ 856% |
| Taxes670/3 | €1.49M | €11.80M | ▲ 693% |
| Tax adjustments and reversals of tax provisions77 | €332k | €744k | ▲ 124% |
| Profit (loss) for the period9904 | €-299.63M | €-215.40M | ▲ 28.1% |
| Profit (loss) for the period to be appropriated9905 | €-299.63M | €-215.40M | ▲ 28.1% |
| Line | 2023 | 2024 | Change |
|---|---|---|---|
| Assets | |||
| Total assets20/58 | €11.67B | €10.69B | ▼ 8.4% |
| Fixed assets21/28 | €8.46B | €9.20B | ▲ 8.8% |
| Intangible fixed assets21 | €36.00M | €45.31M | ▲ 25.9% |
| Tangible fixed assets22/27 | €72.79M | €85.90M | ▲ 18.0% |
| Land and buildings22 | €51.06M | €56.71M | ▲ 11.0% |
| Plant, machinery and equipment23 | €11.64M | €10.03M | ▼ 13.8% |
| Furniture and vehicles24 | €1.61M | €2.02M | ▲ 25.2% |
| Assets under construction and advance payments27 | €8.48M | €17.15M | ▲ 102% |
| Financial fixed assets28 | €8.35B | €9.07B | ▲ 8.6% |
| Affiliated companies280/1 | €8.34B | €9.06B | ▲ 8.7% |
| Participating interests280 | €7.96B | €7.61B | ▼ 4.4% |
| Amounts receivable281 | €377.68M | €1.45B | ▲ 283% |
| Other financial fixed assets284/8 | €11.31M | €10.19M | ▼ 9.8% |
| Shares284 | €10.63M | €9.49M | ▼ 10.7% |
| Amounts receivable and cash guarantees285/8 | €675k | €701k | ▲ 3.8% |
| Current assets29/58 | €3.22B | €1.49B | ▼ 53.6% |
| Amounts receivable within one year40/41 | €2.40B | €1.07B | ▼ 55.4% |
| Trade receivables40 | €539.13M | €509.18M | ▼ 5.6% |
| Other amounts receivable41 | €1.86B | €561.43M | ▼ 69.8% |
| Current investments50/53 | €455.00M | €172.56M | ▼ 62.1% |
| Own shares50 | - | €70.21M | - |
| Other investments51/53 | €455.00M | €102.35M | ▼ 77.5% |
| Cash at bank and in hand54/58 | €349.28M | €229.98M | ▼ 34.2% |
| Deferred charges and accrued income490/1 | €13.05M | €19.54M | ▲ 49.7% |
| Equity and liabilities | |||
| Total equity and liabilities10/49 | €11.67B | €10.69B | ▼ 8.4% |
| Equity10/15 | €8.03B | €7.58B | ▼ 5.6% |
| Contributions10/11 | €2.37B | €2.37B | = |
| Capital10 | €1.35B | €1.35B | = |
| Issued capital100 | €1.35B | €1.35B | = |
| Outside capital11 | €1.02B | €1.02B | = |
| Share premium1100/10 | €1.02B | €1.02B | = |
| Reserves13 | €1.87B | €1.80B | ▼ 3.4% |
| Non-distributable reserves130/1 | €135.16M | €205.37M | ▲ 52.0% |
| Legal reserve130 | €135.16M | €135.16M | = |
| Own shares acquired1312 | - | €70.21M | - |
| Tax-exempt reserves132 | €653.38M | €653.38M | = |
| Distributable reserves133 | €1.08B | €943.20M | ▼ 12.4% |
| Profit (loss) carried forward14 | €3.79B | €3.41B | ▼ 10.2% |
| Provisions and deferred taxes16 | €90.63M | €120.15M | ▲ 32.6% |
| Provisions for liabilities and charges160/5 | €90.63M | €120.15M | ▲ 32.6% |
| Pensions and similar obligations160 | €8.50M | €21.02M | ▲ 147% |
| Other liabilities and charges164/5 | €82.14M | €99.13M | ▲ 20.7% |
| Amounts payable17/49 | €3.55B | €2.99B | ▼ 15.8% |
| Amounts payable after more than one year17 | €1.60B | €1.00B | ▼ 37.5% |
| Financial debts170/4 | €1.60B | €1.00B | ▼ 37.5% |
| Subordinated loans170 | €500.00M | €500.00M | = |
| Unsubordinated bonds171 | €500.00M | €500.00M | = |
| Credit institutions173 | €600.00M | - | - |
| Other loans174 | €192k | - | - |
| Other amounts payable178/9 | €1.23M | €1.23M | = |
| Amounts payable within one year42/48 | €1.94B | €1.98B | ▲ 2.1% |
| Financial debts43 | €10.58M | €50.51M | ▲ 377% |
| Credit institutions430/8 | €10.37M | €50.00M | ▲ 382% |
| Other loans439 | €209k | €503k | ▲ 141% |
| Trade debts44 | €69.74M | €112.49M | ▲ 61.3% |
| Suppliers440/4 | €69.74M | €112.49M | ▲ 61.3% |
| Advances received on contracts in progress46 | €7.39M | €7.81M | ▲ 5.7% |
| Taxes, remuneration and social security45 | €122.12M | €101.72M | ▼ 16.7% |
| Taxes450/3 | €92.79M | €63.64M | ▼ 31.4% |
| Remuneration and social security454/9 | €29.33M | €38.09M | ▲ 29.8% |
| Other amounts payable47/48 | €1.73B | €1.71B | ▼ 1.3% |
| Accrued charges and deferred income492/3 | €11.48M | €10.73M | ▼ 6.5% |
| Line | 2023 | 2024 | Change |
|---|---|---|---|
| Profit (loss) for the period9904 | €-299.63M | €-215.40M | ▲ 28.1% |
| + Depreciation and write-downs630 | €11.02M | €24.88M | ▲ 126% |
| Operating cash flow (approximation) | €-288.61M | €-190.52M | ▲ 34.0% |
| Investment in fixed assets (approximation) | - | €-768.03M | - |
| Change in cash | - | €-119.31M | - |
Simplified and derived: a Belgian filing has no cash-flow statement, so these rows come from the income statement and the balance-sheet moves.
Timeline · acts, filings and financial milestones
09-07
State Gazette act
Resignations: Rosemary Thorne, Roeland Baan and 4 othersAppointments: Miguel Mantas, Kerstin Artenberg and 7 others · Permanent representative: Marie Kaisin31 facts ▸
- Board meeting, 02/03/2026
- Director resignation, Rosemary Thorne (chair)
- Director resignation, Rosemary Thorne (administratrice indépendante non exécutive)
- Director resignation, Roeland Baan (administrateur non exécutif)
- Director appointment, Miguel Mantas (administrateur indépendant non exécutif)
- Director appointment, Kerstin Artenberg (membre de l'executive leadership team (personne déléguée à la gestion journalière))
- Board meeting, 23/03/2026
- Director appointment, Martine Snels (administratrice indépendante non exécutive)
- Board meeting, 13/05/2026
- Director resignation, Julian Waldron (administrateur non exécutif)
- Director appointment, Thomas Bucher (administrateur indépendant non exécutif)
- Director appointment, Thomas Bucher (président du comité d'audit et de risques)
- +19 further facts in this act
27-02
State Gazette act
Appointment: Michael Radossich (ceo)Resignations: Ilham Kadri (ceo en bestuurder) and Marc Chollet (chief strategy officer en lid van het elt)7 facts ▸
- Board meeting, 16/09/2025
- Board meeting, 12/12/2025
- Director appointment, Michael Radossich (ceo (persoon belast met dagelijks bestuur))
- Director appointment, Michael Radossich (uitvoerend bestuurder van de raad van bestuur)
- Director resignation, Ilham Kadri (ceo en bestuurder)
- Director resignation, Ilham Kadri (lid van de raad)
- Director resignation, Marc Chollet (chief strategy officer en lid van het elt (persoon belast met dagelijks bestuur))
01-10
State Gazette act
Resignations: Nadine Duchemin-Lesfie (independent director) and Matti Lievonen (independent director)Appointments: Cynthia Arnold (independent director) and Augusto Di Donfrancesco (non-executive director)5 facts ▸
- Board meeting, 15/07/2025
- Director resignation, Nadine Duchemin-Lesfie (independent director)
- Director resignation, Matti Lievonen (independent director)
- Director appointment, Cynthia Arnold (independent director)
- Director appointment, Augusto Di Donfrancesco (non-executive director)
06-06
State Gazette act
Resignation: Mark Rollinger (general counsel en lid van het uitvoerend comité)Appointment: Brian Belanger (general counsel en lid van het uitvoerend comité)3 facts ▸
- Board meeting, 25/02/2025
- Director resignation, Mark Rollinger (general counsel en lid van het uitvoerend comité)
- Director appointment, Brian Belanger (general counsel en lid van het uitvoerend comité)
15-05
State Gazette act
Capital & shares · Statutes amendmentShare cancellation · Reserve release · Capital5 facts ▸
- Share cancellation, 445.001, verworven eigen aandelen in het kader van kader van de derde tranche van het programma (tot 7 mei 2025)
- Reserve release, onbeschikbare reserves worden opgeheven
- Capital, €1.351.624.292,82
- Power of attorney, Valérie Demeur
- Power of attorney, Patricia Van de Wiele
24-03
State Gazette act
Capital & shares · Statutes amendmentShare cancellation · Reserve release · Capital6 facts ▸
- Share cancellation, 666655, 470.783 eigen aandelen (tweede tranche) + 195.872 eigen aandelen (derde tranche)
- Reserve release, onbeschikbare reserves worden opgeheven
- Capital, €1.351.624.292,82
- Power of attorney, Aminata Kaké
- Power of attorney, Olivia Szerer
- Power of attorney, Van Halteren Notarissen
06-01
State Gazette act
Statutes amendmentShare cancellation · Reserve release · Capital6 facts ▸
- Share cancellation, 185.000
- Reserve release
- Capital, €1.351.624.292,82
- Power of attorney, Aminata Kaké
- Power of attorney, Olivia Szerer
- Power of attorney, Van Halteren Notarissen
10-12
State Gazette act
Capital & sharesShare cancellation · Reserve release · Capital7 facts ▸
- Share cancellation, verworven eigen aandelen in het kader van de eerste tranche van het programma
- Reserve release, onbeschikbare reserves worden opgeheven
- Capital, €1.351.624.292,82
- Power of attorney, Aminata Kaké
- Power of attorney, Olivia Szerer
- Power of attorney, medewerkers notariskantoor Van Halteren Notarissen
- Power of attorney, elk bestuurder
Show earlier events
26-09
State Gazette act
Resignation: Joelle Boxus (chief people officer en lid van het uitvoerend comite)Appointments: Herve Tiberghien, Dr. Ilham Kadri and 3 others8 facts ▸
- Board meeting, 29/07/2024
- Director resignation, Joelle Boxus (chief people officer en lid van het uitvoerend comite)
- Director appointment, Herve Tiberghien (chief people officer)
- Director appointment, Dr. Ilham Kadri (chief executive officer en voorzitter van het directiecomite)
- Director appointment, Christopher Davis (chief financial officer)
- Director appointment, Herve Tiberghien (chief operations officer en chief people officer)
- Director appointment, Marc Chollet (chief strategy officer)
- Director appointment, Mark Rollinger (group general counsel)
25-09
State Gazette act
Resignation: Joëll Boxus (chief people officer et membre du comité exécutif)Appointment: Hervé Tiberghien (chief people officer)3 facts ▸
- Board meeting, 29/07/2024
- Director resignation, Joëll Boxus (chief people officer et membre du comité exécutif)
- Director appointment, Hervé Tiberghien (chief people officer)
29-03
State Gazette act
MiscellaneousPower of attorney1 fact ▸
- Power of attorney, SCHATTEMAN Belinda Françoise Julia
02-02
State Gazette act
Capital & shares · Statutes amendment · Resignations & appointments · RestructuringResignations: Ilham Kadri (director) and Hervé Tiberghien (director) · Appointments: Rosemary Thorne, Ilham Kadri and 8 others · Demerger20 facts ▸
- General meeting, 08/12/2023
- Demerger, Partiële splitsing van Solvay, waarbij de Specialty Perimeter wordt afgesplitst en ingebracht in Syensqo.
- Capital increase, €1.351.562.792,82
- Accounting effect, 01/07/2023
- Director resignation, Ilham Kadri (director)
- Director resignation, Hervé Tiberghien (director)
- Director appointment, Rosemary Thorne (director)
- Director appointment, Ilham Kadri (director)
- Director appointment, Edouard Janssen (director)
- Director appointment, Françoise de Viron (director)
- Director appointment, Mary Meaney (director)
- Director appointment, Heike Van de Kerkhof (director)
- +8 further facts in this act
12-01
State Gazette act
Appointments: Rosemary Thorne, Françoise de Viron and 13 othersResignation: Hervé Tiberghien (director) · Power of attorney21 facts ▸
- Board meeting, December 2023
- Director appointment, Rosemary Thorne (chair of the board)
- Director appointment, Françoise de Viron (vice voorzitter van de raad van bestuur)
- Director appointment, Ilham Kadri (director)
- Director appointment, Roeland Baan (director)
- Director appointment, Edouard Janssen (director)
- Director appointment, Nadine Leslie (director)
- Director appointment, Matti Lievonen (director)
- Director appointment, Mary Meaney (director)
- Director appointment, Heike Van de Kerkhof (director)
- Director appointment, Julian Waldron (director)
- Director resignation, Hervé Tiberghien (director)
- +9 further facts in this act
03-11
State Gazette act
RestructuringAppointment: Ernst & Young Bedrijfsrevisoren SRL (company auditor) · Demerger · Accounting effect13 facts ▸
- Board meeting, 17/10/2023
- Board meeting, 20/10/2023
- Demerger, Solvay SA/NV
- Accounting effect, 01/07/2023
- Auditor appointment, Ernst & Young Bedrijfsrevisoren SRL (company auditor)
- Auditor appointment, Ernst & Young Bedrijfsrevisoren SRL (company auditor)
- Mandate compensation, Ernst & Young Bedrijfsrevisoren SRL
- Mandate compensation, Ernst & Young Bedrijfsrevisoren SRL
- Exchange ratio, 1 Syensqo share for 1 Solvay share
- Cash consideration, None
- Special benefit, retentiepremie, aandelenopties, bruto premie 12.000.000,00 euro
- Special benefit, retentiepremie, aandelenopties
- +1 further facts in this act
26-10
State Gazette act
Resignations: KADRI Ilham (director) and HAJJAR Karim (director)Appointments: KADRI Ilham (director) and TIBERGHIEN Hervé François Régis (director) · Registered-office move · Capital increase15 facts ▸
- General meeting, 16-10-2023
- Registered-office move, 1130 Brussel, Raketstraat 98
- Capital increase, €61.499
- Bank account, BNP Paribas Fortis, BE25 0019 6216 3082
- Name change, SYENSQO
- Legal-form conversion, naamloze vennootschap
- Net-asset statement, 31-08-2023
- Capital, €61.500
- Director resignation, KADRI Ilham (director)
- Director resignation, HAJJAR Karim (director)
- Director appointment, KADRI Ilham (director)
- Director appointment, TIBERGHIEN Hervé François Régis (director)
- +3 further facts in this act
28-06
State Gazette act
Resignation: Solvay SA (director)Appointments: Ilham Kadri (director) and Karim Hajjar (director) · Permanent representative: Marie Kaisin · Director discharge8 facts ▸
- General meeting, 24 mai 2023
- Director resignation, Solvay SA (director)
- Director discharge, Solvay SA (director)
- Director appointment, Ilham Kadri (director)
- Mandate compensation, Ilham Kadri
- Director appointment, Karim Hajjar (director)
- Mandate compensation, Karim Hajjar
- Permanent representative, Marie Kaisin (représentant permanent du commissaire)
22-06
State Gazette act
Resignation: Solvay SA (director)Appointments: Ilham Kadri (director) and Karim Hajjar (director) · Permanent representative: Marie Kaisin · Director discharge10 facts ▸
- General meeting, 24/05/2023
- Director resignation, Solvay SA (director)
- Director discharge, Solvay SA (director)
- Director appointment, Ilham Kadri (director)
- Mandate compensation, Ilham Kadri
- Director appointment, Karim Hajjar (director)
- Mandate compensation, Karim Hajjar
- Permanent representative, Marie Kaisin
- Power of attorney, Aminata Kaké
- Power of attorney, Kathleen Dierckx
01-03
State Gazette act
IncorporationAppointments: SOLVAY (sole director) and Ernst & Young Réviseurs d’Entreprises (statutory auditor) · Permanent representative: d’OREYE de LANTREMANGE Louis François Marie Ghislain · Founder7 facts ▸
- Incorporation, 27/02/2023
- Founder, SOLVAY
- Founding capital, €1
- Director appointment, SOLVAY (sole director)
- Permanent representative, d’OREYE de LANTREMANGE Louis François Marie Ghislain
- Mandate compensation, SOLVAY
- Auditor appointment, Ernst & Young Réviseurs d’Entreprises (statutory auditor)
01-03
State Gazette act
IncorporationAppointments: SOLVAY (director) and Ernst en Young Bedrijfsrevisoren (statutory auditor) · Permanent representative: d’OREYE de LANTREMANGE Louis François Marie Ghislain · Founder11 facts ▸
- Incorporation, 27-02-2023
- Founder, SOLVAY
- Founding capital, €1
- Director appointment, SOLVAY (director)
- Permanent representative, d’OREYE de LANTREMANGE Louis François Marie Ghislain
- Mandate compensation, SOLVAY
- Auditor appointment, Ernst en Young Bedrijfsrevisoren (statutory auditor)
- Power of attorney, Didier Collard
- First ordinary general meeting, 2024
- Share subscription, 1
- Auditor compensation, bepaald door de eerstvolgende algemene vergadering
About the unread acts
Of the 33 Belgian State Gazette acts we know for this company, 30 have been read. The other 3 have not been read yet: what they contain is neither established nor disproved here.
Directors · office · real estate
11 other directors
Not every act has been read: a resignation may be missing here
1 establishment unit
1 parcel
| Parcel (capakey) | Region | Area | Buildings | Height / fl. |
|---|---|---|---|---|
| 21821C0238/00C000 | Brussels | 9,849 m² | 1 · 3,799 m² | 19.4 m · 5 fl. |
Linked by address, not proof of ownership
Statutory auditor
2 auditors| Ernst & Young Réviseurs d'Entreprises SRLCurrent Statutory auditor · represented by Marie Kaisin | 01-03-2023 → present |
| Ernst & Young Réviseurs d'Entreprises SRLCurrent Mission d'assurance limitée relative à l'information en matière de durabilité · represented by Marie Kaisin | 09-07-2026 → present |
Articles of association
Full purpose
Direct of indirect aandelen te bezitten en te beheren in vennootschappen, ondernemingen of instellingen met een bedrijfsdoel dat direct of indirect verband houdt met het vervaardigen, exploiteren, verhandelen, onderzoeken en ontwikkelen van industriële en commerciële activiteiten of diensten in met name, maar niet alleen de chemische sector...; productie, exploitatie-, verhandelings-, onderzoeks-, ontwikkelings-, behandelings-, verwerkings-, transport- en beheeractiviteiten te ontplooien...; aanleggen, uitbouwen en beheren van onroerend vermogen; aanleggen, uitbouwen en beheren van roerend vermogen; aangaan en verstrekken van leningen, kredieten, financieringen en leasingcontracten.
Structure & network
Connections & network
13 connected companiesShow 9 more companies with a shared director
Ownership & control
1 parent company · 1 subsidiary, 1 abroadAcquisitions and mergers
1 transactionGroup per the LEI register
1 branchCapital and shareholders
- SOLVAY (BE 0403.091.220)
- SOLVAY (BE 0403.091.220) sole founder · 100% at incorporation
The Belgian State Gazette names shareholders only when an act mentions them; the share register itself is not published.
- 15-05-2025 Capital stated in the act · 1,351,624,292.82 EUR · 103,921,273 shares
- 24-03-2025 Capital stated in the act · 1,351,624,292.82 EUR · 104,366,274 shares
- 06-01-2025 Capital stated in the act · 1,351,624,292.82 EUR
- 10-12-2024 Capital stated in the act · 1,351,624,292.82 EUR · 105,217,929 shares
- 02-02-2024 Capital increase of 1,351,562,792.82 EUR · to 1,351,624,292.82 EUR
- 26-10-2023 Capital increase of 61,499 EUR · in cash
- 01-03-2023 Incorporation · 1 EUR · 1 share
Public money · subsidies and aid
European research
3 projects · 338,783 EUR EU contributionRecognitions · licences · registrations
Legal Entity Identifier
Similar companies · same sector, comparable size
Identification & contact
Scores and ratios are computed by Checked and are not a credit decision.